It was discovered that NPM1 mutated AML is also driven by HOX gene overexpression similar to that of KMT2A rearranged AML, and that growth of NPM1 mutated leukemic cells could be arrested by treating with Menin inhibitors [63, 64]. The gene discussed is NPM1; the disease is acute myeloid leukemia.